ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Natco Pharma consolidated net profit up 27% to Rs 80 crore in Dec quarter
The Hyderabad-based company had reported a net profit of Rs 63.4 crore in the October-December period of previous fiscal
Announcement as on 14 February 2022

Natco Pharma signs pact with MPP to sell Molnupiravir capsules
Natco Pharma has signed a non-exclusive license agreement with the Medicines Patent Pool (MPP), Switzerland to manufacture and sell Molnupiravir capsules 200 mg for treatment of COVID-19. MPP had taken licence from Merck Sharp & Dohme Corp (MSD), USA for t
Announcement as on 20 January 2022

Natco Pharma signs agreement with MPP to sell Molnupiravir capsules
Natco Pharma Ltd on Thursday said it has signed a non-exclusive license agreement with the Medicines Patent Pool (MPP), Switzerland to manufacture and sell Molnupiravir capsules 200 mg for treatment of COVID-19. MPP had taken licence from Merck Sharp & Doh
Announcement as on 20 January 2022

Here's why HDFC Securities recommends buying VRL Logistics, Natco Pharma
Logistics stocks have been showing strength on the medium term charts, according to Vinay Rajani of HDFC Securities.
Announcement as on 12 January 2022

Natco Pharma plans to launch Molnupiravir capsules this week for treatment of COVID-19
Molnupiravir is the first COVID-19 drug authorised by the Drugs Controller General of India (DCGI) for the treatment of COVID-19 infection in adults who have high risk of progression of the disease including hospitalisation or death.
Announcement as on 28 December 2021

Announcements by Natco Pharm first page | Next page | Prev page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 886.96
  • 12Day Average: 904.36
  • 20Day Average: 912.71
  • 50Day Average: 918.65
  • 100Day Average: 997.18
  • 150Day Average: 964.28
  • 200Day Average: 943.1

524816 Indicators & signals

Indicator MACD (12,26,9)

901.16, 915.18, -10.8
Indicator MACD is in negative zone

Indicator ADX (14)

6.56, 20.42, 17.91
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 47
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
21 Fri Aug 2026 882.50 877.95 to 900.00 0.54% 0.74 times
20 Thu Aug 2026 877.75 875.30 to 894.30 -1.05% 0.68 times
19 Wed Aug 2026 887.05 883.10 to 916.60 -1.2% 0.29 times
18 Tue Aug 2026 897.80 889.70 to 900.10 0.91% 0.37 times
17 Mon Aug 2026 889.70 870.70 to 898.85 -1.41% 1.2 times
14 Fri Aug 2026 902.40 885.75 to 962.25 -5.23% 3.7 times
13 Thu Aug 2026 952.25 917.60 to 960.40 4.07% 1.64 times
12 Wed Aug 2026 915.00 906.00 to 922.00 0.89% 0.48 times
11 Tue Aug 2026 906.90 903.55 to 929.40 -0.5% 0.77 times
10 Mon Aug 2026 911.50 905.55 to 932.00 -0.62% 0.73 times
07 Fri Aug 2026 917.15 912.00 to 921.10 0.53% 0.14 times
06 Thu Aug 2026 912.35 910.00 to 932.75 -0.58% 0.75 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top